The event, hosted by Soledad Cabezón Ruiz MEP, will feature a discussion with Members of the European Parliament and policy advisors, EU policymakers, experts and stakeholders in the field of health research. Through the example of the HARMONY Alliance, the debate touched upon challenges and opportunities of using big data and eHealth services in healthcare systems.
Two sessions at the European Parliament
Jesús María Hernández Rivas, Coordinator of the HARMONY Alliance, participated as a speaker in two sessions about digitalisation in healthcare that have been organised at the European Parliament for the members of this institution. In these two consecutive sessions, also attended by other decision makers and experts in healthcare, Prof. Dr. Hernández Rivas has presented the advantages of incorporating big data technologies to healthcare, which will ultimately result in more digital and sustainable healthcare systems.
The session ‘Big data in health - IMI’s HARMONY project: How to improve healthcare services through big data and research’ has gathered experts in healthcare and big data, policy makers and researchers. The debate has dealt about the opportunities offered by new technologies in the health sector and the challenges they pose. Prof. Dr. Hernández Rivas has presented HARMONY as an example of how it is possible to implement safe technological solutions within healthcare systems while benefitting patients, protecting their privacy, and safeguarding and boosting research.
The workshop on ‘Digitalisation and Big Data: implications for the health sector’ for the European Parliament’ has immediately followed the first session. Here, Prof. Dr. Hernández Rivas has emphasised the importance of gathering and sharing data at a European level, especially for rare diseases such as hematologic malignancies. In addition to its 53 public and private Partners, the HARMONY Alliance counts already 24 European institutions as recently appointed Associated Members, all of great relevance in the field of Haematology. By sharing their data and present research proposals HARMONY partners are aiming to identify specific marker and to develop innovative and effective treatments for specific blood cancers.
Receive the latest news. Click here to subscribe!
Public-private partnership for Big Data in Hematology
HARMONY and HARMONY PLUS are funded through the Innovative Medicines Initiative (IMI), Europe's largest public-private initiative aiming to speed up the development of better and safer medicines for patients. Funding is received from the IMI 2 Joint Undertaking and is listed under grant agreement for HARMONY No. 116026 and grant agreement for HARMONY PLUS No. 945406. This Joint Undertaking receives support from the European Union’s Horizon 2020 Research and Innovation Programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA).
HARMONY Coordination Office
Institute of Biomedical Research of
Salamanca (IBSAL)
Salamanca, Spain
HARMONY Communications
European Hematology Association (EHA)
The Hague, The Netherlands
